Equra Health

Clinical Research

Alpha Oncology is morally committed to the fight against the rising incidence of cancer worldwide. Alpha's devotion to the improvement in treatments available to patients with cancer is testimony to this commitment. In this regard Alpha has established four comprehensive Clinical Research Units (CRU's) at its' Cancer Centres in Rondebosch and Cape Gate (Cape Town); Port Elizabeth and George. Alpha's CRU's are proud to have recently been accredited as centres of excellence by a prominent multinational pharmaceutical company.

The clinical research programme is conducted in collaboration with large academic cancer centres and cooperative oncology groups worldwide, as well as other major role players in new anti-cancer drug development e.g. the pharmaceutical industry. The clinical trials offered to patients at our units are typically late phase development studies in which new agents with major potential are compared with the current standard-of-care. These studies are usually phase III studies, implying the phase of development directly preceding the marketing of a new treatment. A phase IV post marketing programme is also conducted in which post-marketing studies investigate possible further toxicities and "fine tuning" of new and older treatments already available to patients in the public domain.

All cancer patients treated at our units are encouraged to discuss possible participation in new research with their oncologists as one of the treatment options for their specific cancer.